close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. William Oh

location-icon

Greenwich, CT

LOCATION OF PRACTICE
Yale New Haven Hospital
MEDICAL Specialty:

Metastatic Respiratory System Cancer, Prostate Cancer, Thyroid Cancer



77 LAFAYETTE PL, GREENWICH, CT, 068305437
333 CEDAR STREET, PO BOX 208028, NEW HAVEN, CT, 06520
203-863-3700
NPI Number
1225095581
ABOUT

William Oh, MD, is a Medical Oncologist in Ruttenberg Treatment Center in New York, NY. He frequently treats conditions such as Metastatic Respiratory System Cancer, Prostate Cancer, and Thyroid Cancer. Oh completed a fellowship at Dana Farber Cancer Institute and a residency at Brigham and Women’s Hospital.

Dr. William Oh profile image

Published Articles

Bazedoxifene reverses sexually dimorphic autistic-like abnormalities in biallelic MDGA1-mutant mice.- 2026 Mar 20
Oral Consumption of Cannabidiol During Pregnancy Alters Behavior in Mouse Offspring.- 2026 Apr
Serotonergic modulation of excitatory synapse development and plasticity.- 2026 Mar 10
A forensic investigation and simulation-based analysis of a chemical plant explosion accident.- 2026 Mar 6
Integrative Roles of NK Receptors and γδ TCRs in γδ T Cell-Mediated Cancer Immunity.- 2026 Feb
Fat promotes growth and invasion in a 3D microfluidic tumor model of triple-negative breast cancer.- 2026 Mar
Targeting COL6A3-C5 with nigericin suppresses endotrophin formation and enhances insulin sensitivity in obesity.- 2026 Mar
Demographic and epidemiological factors associated with COVID-19 superspreading persons in Gangwon province.- 2026 Mar 4
GAFAD: An LC-MS/MS-Based Model for Early Hepatocellular Carcinoma Detection Beyond GALAD's Limitation.- 2026 Feb 25
Competencies influencing childcare providers' infectious-disease prevention in routine and outbreak contexts: a study in South Korea.- 2025

Clinical Trials

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Spectra Breast Implant Study
Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider